Image analysis systems for the detection of disseminated breast cancer cells on bone‐marrow cytospins
- 1 January 2005
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 19 (3) , 115-119
- https://doi.org/10.1002/jcla.20064
Abstract
We assessed the accuracy of automated cell imaging systems when compared to manual evaluation of cytospin slides in determining the presence of cytokeratin‐positive, disseminated breast cancer cells in bone marrow aspirates. A total of 298 cytospin slides of bone marrow aspirates were first evaluated by individual screening by one expert immunocytologist. Subsequently, all 298 slides were evaluated by the Automated Cell Imaging System (ACIS) by ChromaVision™. Two separate analysis cycles were performed using ACIS. The results of the two ACIS analysis cycles were almost identical: in 293 out of 298 samples (98.3%), identical numbers of disseminated breast cancer cells were detected. In the remaining five samples (1.7%), the result of the two ACIS analysis cycles differed by only one tumor cell. By using the manual technique, 120 cytospin samples were found to be positive. ACIS was able to detect additional tumor cells in 64 cases. Not once did ACIS miss tumor cells when compared to the manual technique. Using ACIS, we were able to determine the bone marrow status of patients with nonmetastatic breast cancer faster, with greater accuracy, and with greater reproducibility than with the manual technique. J. Clin. Lab. Anal. 19:115–119, 2005.Keywords
This publication has 17 references indexed in Scilit:
- Minimal Residual Disease in Gastric Cancer: Evidence of an Independent Prognostic Relevance of Urokinase Receptor Expression by Disseminated Tumor Cells in the Bone MarrowJournal of Clinical Oncology, 2002
- Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients.2001
- Disseminierte Melanomzellen in Blut und KnochenmarkDie Dermatologie, 2001
- Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast CancerNew England Journal of Medicine, 2000
- Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancerCancer Treatment Reviews, 2000
- Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up studyThe Lancet, 1999
- Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cellsCytotherapy, 1999
- Micrometastatic Breast Cancer Cells in Bone Marrow at Primary Surgery: Prognostic Value in Comparison With Nodal StatusJNCI Journal of the National Cancer Institute, 1996
- Detection of Occult Bone Marrow Micrometastases in Patients with Operable Lung CarcinomaAnnals of Surgery, 1995
- Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years' follow-upEuropean Journal of Cancer and Clinical Oncology, 1991